Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Interactions between St. John's wort and rosiglitazone

March 21, 2005

New phase I data on the efficacy of PBI-1402 in anemia

March 21, 2005

Symlin receives FDA approval

March 18, 2005

Orion reports a novel series of SARMs

March 18, 2005

Oxytocin antagonists from GlaxoSmithKline reported in patent literature

March 18, 2005

Dainippon obtains development and marketing rights for KGA-2727 in Japan

March 18, 2005

FDA rejects Public Citizen's petition for Crestor

March 18, 2005

MediciNova opens phase I study for MN-221

March 18, 2005

MCHR1 antagonist shows notable selectivity and good PK profile

March 17, 2005

First data describing MB-06322, an antidiabetic agent in phase II trials

March 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...